Tau-based therapies in neurodegeneration: opportunities and challenges. - Wikidata - thesis-toulmin - TriplyDB

Tau-based therapies in neurodegeneration: opportunities and challenges.

Tau-based therapies in neurodegeneration: opportunities and challenges.

http://www.wikidata.org/entity/Q47689697

about

Alzheimer's disease hypothesis and related therapies.Safety and Efficacy of Scanning Ultrasound Treatment of Aged APP23 Mice.An Overview on the Clinical Development of Tau-Based Therapeutics.The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer's Disease.Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.Steroids and Brain, a Rising Bio-Medical Domain: a Perspective.Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine.Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau The distinct structural preferences of tau protein repeat domains Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau IgM response against amyloid-beta in aging: a potential peripheral protective mechanism

P2860

Q49762112-791CD33D-A4B0-4B32-830A-5E55AD12DAD6 Q50535401-12E29260-11AB-4A19-B64D-BBC2E4B8A674 Q52594209-25745DE0-58C8-4084-8544-5F2BC118D720 Q53403638-6B8E84CE-FCB1-4E19-8B67-DBE27D2C4B73 Q54978673-20C778F4-0081-4BA5-BD67-B036FB6CB1DF Q55397816-2B33EFA8-C0DA-4D58-9747-44110A48E1E8 Q55399027-DBA73579-A10E-48BF-A015-64647F01A823 Q55405917-C41EBF15-A340-494E-9C18-2F0C4E49B244 Q56889147-CFEDBA01-74D4-4B53-AEBC-544527EEAA21 Q57840232-A4A9BA27-E7EA-4F04-AD8D-174815438676 Q58708935-26624EA2-1796-4CCE-B15C-AB2EB1B8EE8D Q58773839-355C9EC6-5029-4973-BB44-E53EEA13BEF2

P2860

Tau-based therapies in neurodegeneration: opportunities and challenges.

http://www.wikidata.org/entity/Q47689697

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Tau-based therapies in neurodegeneration: opportunities and challenges.

@en

Tau-based therapies in neurodegeneration: opportunities and challenges.

@nl

type

label

Tau-based therapies in neurodegeneration: opportunities and challenges.

@en

Tau-based therapies in neurodegeneration: opportunities and challenges.

@nl

prefLabel

Tau-based therapies in neurodegeneration: opportunities and challenges.

@en

Tau-based therapies in neurodegeneration: opportunities and challenges.

@nl

P1433

Q47689697-4AE064AC-7678-4049-A549-CA490CF827AF

P1476

Q47689697-FE6BB18B-9747-48AC-A412-5189EC01F3A4

P2093

Q47689697-0CED86AC-B9EF-4A0C-A8D8-1E131AE172B7

Q47689697-D4712D71-6250-4107-ADC4-FA771A398429

P2860

Q47689697-00485A7D-3E74-4DB0-864D-016E31F6D7DB

Q47689697-006BEDD4-ED07-40A2-8453-10BC75AE6495

Q47689697-01F5AD85-C678-4B4F-B1AE-9D403314146D

Q47689697-035E5DC4-C166-4F9C-A631-1A2B1A37CD0C

Q47689697-03B5265D-3685-4401-AF29-8E995D7F8D0E

Q47689697-03CD7429-B9B8-4F67-898D-A281FB5C2DD2

Q47689697-040C32A7-EBE9-404E-A8DD-B7675D84723F

Q47689697-0502E4E9-5D57-44C9-9D32-8DD3D7A6D5BE

Q47689697-072E14B4-0C8A-4A2E-BF32-B2D1D201C366

Q47689697-086EA8C2-292E-433D-9666-89CE9195BDE1

P2888

Q47689697-C3245D0E-6ADE-44C7-B9B9-51434B973821

P304

Q47689697-1951A0FA-611F-4AC5-BF7A-241BC8C3C487

P31

Q47689697-0E086906-2EA9-4FDF-985B-B34DBCCC76A1

P356

Q47689697-78071DB9-51C6-4A17-9306-FC46250DF362

P433

Q47689697-C850040A-A4DC-44DA-9453-244E85A008FD

P478

Q47689697-F6E57AE9-D5D6-4433-93B8-E02A3C3DED94

P577

Q47689697-A17B5301-16E9-49EA-91A9-3F13CA2A8932

P698

Q47689697-E25975EB-54BF-4291-A3D4-37489F58576D

P356

P1433

Nature Reviews Drug Discovery

P1476

Tau-based therapies in neurodegeneration: opportunities and challenges.

@en

P2093

Chuanzhou Li

http://www.w3.org/2001/XMLSchema#string

Jürgen Götz

http://www.w3.org/2001/XMLSchema#string

P2860

The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein

Complex Disposition of Methylthioninium Redox Forms Determines Efficacy in Tau Aggregation Inhibitor Therapy for Alzheimer's Disease

Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines

Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib

Reversing EphB2 depletion rescues cognitive functions in Alzheimer model

The amyloid hypothesis of Alzheimer's disease at 25 years

Characteristics of Tau and Its Ligands in PET Imaging

Self-propagation of pathogenic protein aggregates in neurodegenerative diseases

Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy

P2888

P304

863-883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRD.2017.155

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28983098

http://www.w3.org/2001/XMLSchema#string